An Act relative to opioid drug manufacturer assessments
By Ms. Cronin of Easton, a petition (accompanied by bill, House, No. 1703) of Claire D. Cronin and others relative to opioid drug manufacturer assessments. Mental Health, Substance Use and Recovery.
Bill Information
Bill Information
- Presenter:
- Claire D. Cronin
Emergency Preamble
Whereas, The deferred operation of this act would tend to defeat its purposes, which are to establish forthwith for the treatment and prevention of addiction that results from opioid drug manufacturing, dispensing and distribution, therefore it is hereby declared to be an emergency law, necessary for the immediate preservation of the public health.
Bill History
| Date | Branch | Action |
|---|---|---|
| 1/22/2019 | House | Referred to the committee on Mental Health, Substance Use and Recovery |
| 1/22/2019 | Senate | Senate concurred |
| 9/16/2019 | Joint | Hearing scheduled for 09/19/2019 from 10:00 AM-01:00 PM in B-1 |
| 3/9/2020 | House | Accompanied a new draft, see H4532 |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.